SVS Presents...What Do the BEST-CLI Results Mean for the Vascular Surgery Community?
Overview
Recently, the results from the Best Endovascular vs. Best Surgical Therapy in Patients with Critical Limb Ischemia (BEST-CLI) trial were published in the New England Journal of Medicine. The research aimed to figure out the best treatment for patients with PAD associated with CLI. With the data being released, the trial has become a hot topic in the vascular surgery community. Join us on Apr. 12 at 7 p.m. CT for a webcast that will dive into what the BEST-CLI results mean for vascular surgeons. Trial principal investigators, Alik Farber, MD and Matthew Menard, MD will present data, engage in a discussion with the esteemed panel and take questions from the audience.
Topic Area
Arterial Occlusive Disease
Faculty
| Moderators | |
| Caitlin Hicks, MD |
Vincent Rowe, MD |
| Speakers | |
| Alik Farber, MD | Matthew Menard, MD |
| Panelists | |
| Ted Gifford, MD | Linda Harris, MD |
| Sharon Kiang, MD | Robert Molnar, MD |
| Andres Schanzer, MD |
Peter Schneider, MD |
Program Details
7:00 p.m. to 7:02 p.m.
Welcome to SVS Presents! – Linda Harris, MD
7:02 p.m. to 7:05 p.m.
Introductions of faculty and program - Caitlin Hicks, MD and Vincent Rowe, MD
7:05 p.m. to 7:15 p.m.
BEST-CLI Trial Results – Matthew Menard, MD
7:15 p.m. to 7:25 p.m.
Trial Limitations & Points of Interpretation – Alik Farber, MD
7:25 p.m. to 8:25 p.m.
Panel Discussion and Questions from the Audience
8:25 p.m. to 8:30 p.m.
Overview of VAM23, including BEST-CLI sessions - Andres Schanzer, MD
Target Audience
All members of the vascular surgery field are strongly encouraged to attend.
Pricing
| SVS Members (All Categories) | Free |
| Non-Members | $35 |
Submit Your Questions
If you have questions that you would like to ask the panel, please submit them at the form below.